June 2023 FDA Recall Albuterol Sulfate by Cipla Usa, Inc.
D-0938-2023 - Defective container
This Class I drug recall was voluntarily initiated by Cipla Usa, Inc. on June 27, 2023 for the product Albuterol Sulfate. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0938-2023
Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
06-27-2023
07-19-2023
278,538 canisters
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Cipla USA, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the US
03-06-2025
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60
Batch or Lot Expiration Information
Lot# IB20045, IB20055, IB20056, IB20057, IB20059, IB20072, Exp Nov. 30, 2023